Recombinant Human GYG1 Protein, N-His-SUMO

Introduction

Recombinant Human GYG1 Protein, also known as Glycogenin-1, is a key enzyme involved in the synthesis of glycogen, which is the main storage form of glucose in the body. This protein is encoded by the GYG1 gene and is highly conserved across species. Recombinant Human GYG1 Protein is produced through genetic engineering techniques, making it a valuable tool in various research and industrial applications.

Structure of Recombinant Human GYG1 Protein

Recombinant Human GYG1 Protein is a single polypeptide chain consisting of 361 amino acids with a molecular weight of approximately 40 kDa. It contains a glycogenin-1 domain, a glycogenin-2 domain, and a C-terminal domain. The protein also has a conserved glycogenin signature motif and a putative glycogenin active site, which are essential for its enzymatic activity.

Activity of Recombinant Human GYG1 Protein

Recombinant Human GYG1 Protein plays a crucial role in the initiation of glycogen synthesis. It acts as a self-glucosylating enzyme, catalyzing the transfer of glucose from UDP-glucose to a specific tyrosine residue on its own polypeptide chain. This results in the formation of a short glucose polymer, which serves as a primer for the addition of more glucose molecules to form glycogen. This process is known as glycogenin-mediated glycogen synthesis and is essential for the regulation of glucose metabolism in the body.

In addition to its role in glycogen synthesis, Recombinant Human GYG1 Protein has been shown to have other important functions. It has been reported to interact with various proteins involved in glycogen metabolism, such as glycogen synthase, glycogen phosphorylase, and glycogenin-2. These interactions are crucial for the proper functioning of the glycogen synthesis pathway.

Application of Recombinant Human GYG1 Protein

The production of Recombinant Human GYG1 Protein has revolutionized the study of glycogen metabolism and its associated disorders. This protein is widely used as an antigen in various immunoassays, including ELISA and Western blot, for the detection and quantification of glycogenin levels in biological samples. It has also been used in structural studies to elucidate the mechanism of glycogenin-mediated glycogen synthesis.

Moreover, Recombinant Human GYG1 Protein has potential therapeutic applications in the treatment of glycogen storage diseases (GSDs). GSDs are a group of inherited metabolic disorders characterized by abnormal glycogen deposition in various tissues, resulting in severe health complications. Recombinant Human GYG1 Protein can be used as a therapeutic agent to restore glycogen synthesis in GSD patients, thereby improving their overall health and quality of life.

Furthermore, Recombinant Human GYG1 Protein has been utilized in the development of novel drugs targeting glycogen metabolism. It has been shown to interact with small molecules and natural compounds, which can modulate its activity and potentially serve as lead compounds for drug development. This highlights the potential of Recombinant Human GYG1 Protein in the pharmaceutical industry.

Conclusion

In summary, Recombinant Human GYG1 Protein is a crucial enzyme involved in glycogen synthesis, with a well-defined structure and activity. Its production through genetic engineering has enabled its widespread use in various research and industrial applications. With its potential therapeutic and pharmaceutical applications, Recombinant Human GYG1 Protein continues to be a valuable tool in the study of glycogen metabolism and its associated disorders.